Research Article

Comorbidities and New Onset of Type 2 Diabetes Mellitus among Women Living with HIV Receiving Antiretroviral Therapy in Lagos, Nigeria

Veronica Nnenna Victor Enya
Nigerian Institute of Medical Research (NIMR), Nigeria
* Corresponding author
Onaiwu Idahosa Enabulele
University of Benin, Nigeria
Endurance Anthony Ophori
University of Benin, Nigeria
Nkiruka Nonyelum Odunukwe
Nigerian Institute of Medical Research, Nigeria
DOI icon 10.24018/ejmed.2023.5.1.1601

Read Counter
525

Downloads
426

Citations

Share

Article Sidebar

Submitted 2022-11-18
Published 2023-01-25

Read counter = 525 times

Table of Contents

Article Main Content

Background: There is limited gender stratified data in many type 2 diabetes mellitus (T2DM) studies in Africa. This study aimed to determine the prevalence of Comorbidities, New Onset of T2DM and risk factors influencing predisposition to T2DM among women living with HIV (WLWH) and receiving Antiretroviral Therapies. 

Methods: This was a cross-sectional study of females who were 15 years and above with HIV and/or without pulmonary TB attending HIV and TB DOTS clinics in Lagos, Nigeria from January 2019 to October 2021. The socio-demographic data of participants were obtained using questionnaire. Participants who were not known diabetic cases were tested for diabetes based on WHO and ADA standards using glycated haemoglobin (HbA1c) test, fasting plasma glucose and 2 hour 75 g oral glucose post prandial test. CD4 and CD8 counts were carried out using flow cytometer and their cytokines’ levels were determine using ELISA technique. HIV positive patients with signs and symptoms of TB (presumptive TB) were tested using sputum smear microscopy method and gene X-pert technique. We measured Body mass index (BMI) using International System of Units (kg/m2). Information on age, gender, Antiretroviral therapy (ART), values of CD4, weight, height, viral load and cholesterol test results less than 6 months were obtained from the patients’ folders. 

Results: A total of 187 WLWH were studied. Their mean age was 41.93±10.32 years. Fifty-five (27.9%) had BMI values of ≥ 30 kg/m2. Twenty-one (11.2%) had impaired glucose level. Those with T2DM at baseline were 5(2.7%), 17(9.1%) later developed T2DM. There was strong association between newly developed T2DM and obesity odd ratio (OR) 8.21(95% CI 1.30-51.99), interleukin (IL-): IL-6 OR 4.50 (95% CI 0.58-35.15), viral load with OR as 1.34(0.48-3.75), knowledge of diabetes OR 2.24 (95% CI 0.43-11.62), consumption of alcohol OR 2.03(95% CI 0.60-6.90). Twenty (10.7%) WLWH developed pulmonary TB while receiving ART. Co-morbidities recorded were: HIV/T2DM 14(7.5%), HIV/TB 21(11.2%), HIV/TB/T2DM 7(3.7%). A total of 42(22.7%) were on 2nd line ART. 

Conclusion: Prevalence of HIV/TB co-infection, HIV/T2DM comorbidity and HIV/TB/T2DM multimorbidity were high. Also the prevalence of incident TB and new cases of T2DM among the study population were high. There was positive association between development of T2DM while receiving ART and obesity, IL-6, knowledge of diabetes and alcohol consumption. Protease inhibitors were found to influence the development of T2DM among WLWH while receiving ART. 

Recommendation: There is need for promoting awareness of T2DM and its risk factors among WLWH who are receiving ART.

Keywords: Antiretroviral therapy, comorbidities, type 2 diabetes mellitus, women living with HIV

References

  1. UNAIDS. AIDSinfo Online Database. 2017.
     Google Scholar
  2. Sarkar S, Brown TT. Diabetes in people living with HIV. Endotext [Internet]. 2019.
     Google Scholar
  3. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Research and Clinical Practice. 2019; 157: 107843.
    DOI  |   Google Scholar
  4. Goedecke JH, Mtintsilana A, Dlamini SN, Kengne AP. Type 2 diabetes mellitus in African women. Diabetes Research and Clinical Practice. 2017; 123: 87-96.
    DOI  |   Google Scholar
  5. Edition S. IDF diabetes atlas. Int Diabetes Fed. 2015.
     Google Scholar
  6. Adeloye D, Ige JO, Aderemi AV, Adeleye N, Amoo EO, Auta A, et al. Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis. BMJ Open. 2017; 7(5): e015424.
    DOI  |   Google Scholar
  7. Chivese T, Norris SA, Levitt NS. Progression to type 2 diabetes mellitus and associated risk factors after hyperglycemia first detected in pregnancy: A cross-sectional study in Cape Town, South Africa. PLoS Medicine. 2019; 16(9): e1002865.
    DOI  |   Google Scholar
  8. CDC. TB and HIV Coinfection 2016 [updated 2016; cited 2022]. Available from: https://www.cdc.gov/tb/topic/basics/tbhivcoinfection.htm
     Google Scholar
  9. Organization WH. World Health Organization Global Tuberculosis Report 2013. WHO Press, Geneva, Switzerland; 2014.
     Google Scholar
  10. Wang H, Chow SC. Sample size calculation for comparing proportions. Wiley Encyclopedia of Clinical Trials. 2007; 10: 9781118445112.
    DOI  |   Google Scholar
  11. Association AD. Standards of medical care in diabetes-2007. Diabetes Care. 2007; 30(1): S4-S41.
    DOI  |   Google Scholar
  12. FMOH. National AIDS and STI’s Control Programme 2016.
     Google Scholar
  13. Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. Journal of Clinical Microbiology. 2011; 49(12): 4138-41.
    DOI  |   Google Scholar
  14. Adejumo OA, Olusola-Faleye B, Adepoju V, Bowale A, Adesola S, Falana A, et al. Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria. African Health Sciences. 2018; 18(3): 472-8.
    DOI  |   Google Scholar
  15. Watkins NN, Hassan U, Damhorst G, Ni H, Vaid A, Rodriguez W, et al. Microfluidic CD4+ and CD8+ T lymphocyte counters for point-of-care HIV diagnostics using whole blood. Science translational medicine. 2013; 5(214): 214ra170-214ra170.
    DOI  |   Google Scholar
  16. Ginocchio CC, Kemper M, Stellrecht KA, Witt DJ. Multicenter evaluation of the performance characteristics of the NucliSens HIV-1 QT assay used for quantitation of human immunodeficiency virus type 1 RNA. Journal of clinical microbiology. 2003; 41(1): 164-73.
    DOI  |   Google Scholar
  17. Solutions S. Mann-Whitney U Test 2022. [Internet] Available from: www.statisticssolutions.com/free-resources/directory-of-statistical-analyses/mann-whitney-u-test/.
     Google Scholar
  18. Sarfo FS, Norman B, Nichols M, Appiah L, Assibey SO, Tagge R, et al. Prevalence and incidence of pre‐diabetes and diabetes mellitus among people living with HIV in Ghana: evidence from the EVERLAST Study. HIV Medicine. 2021; 22(4): 231-43.
    DOI  |   Google Scholar
  19. Anastos K, Ndamage F, Lu D, Cohen MH, Shi Q, Lazar J, et al. Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women. AIDS Research and Therapy. 2010; 7(1): 1-6.
    DOI  |   Google Scholar
  20. Isa SE, Oche AO, Kang'ombe AR, Okopi JA, Idoko JA, Cuevas LE, et al. Human immunodeficiency virus and risk of type 2 diabetes in a large adult cohort in Jos, Nigeria. Clinical Infectious Diseases. 2016; 63(6): 830-5.
    DOI  |   Google Scholar
  21. Bashir MA, Yahaya AI, Muhammad M, Yusuf AH, Mukhtar IG. Prediabetes Burden in Nigeria: A Systematic Review and Meta-Analysis. Frontiers in Public Health. 2021; 9.
    DOI  |   Google Scholar
  22. Pathmanathan I, Ahmedov S, Pevzner E, Anyalechi G, Modi S, Kirking H, et al. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings. The International Journal of Tuberculosis and Lung Disease. 2018; 22(6): 596-605.
    DOI  |   Google Scholar
  23. Oni T, Youngblood E, Boulle A, McGrath N, Wilkinson RJ, Levitt NS. Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa-a cross sectional study. BMC Infectious Diseases. 2015; 15(1): 1-8.
    DOI  |   Google Scholar
  24. Yusuf AJ, Hassan A, Mamman AI, Muktar HM, Suleiman AM, Baiyewu O. Prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in Northern Nigeria. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2017; 16(1): 48-55.
    DOI  |   Google Scholar
  25. Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B, et al. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clinical Infectious Diseases. 2007; 45(1): 111-9.
    DOI  |   Google Scholar
  26. BrownTT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine. 2005; 165(10): 1179-1184.
    DOI  |   Google Scholar
  27. Karamchand S, Leisegang R, Schomaker M, Maartens G, Walters L, Hislop M, et al. Risk factors for incident diabetes in a cohort taking first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Medicine. 2016; 95(9).
    DOI  |   Google Scholar
  28. Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. Jama. 2010; 304(3): 303-12.
    DOI  |   Google Scholar
  29. Chimbetete C, Mugglin C, Shamu T, Kalesan B, Bertisch B, Egger M, Kaiser O. New‐onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis. Tropical Medicine & International Health. 2017; 22(7): 839-45.
    DOI  |   Google Scholar
  30. Francisco C, Catai A, Moura-Tonello S, Arruda L, Lopes S, Benze B, et al. Cytokine profile and lymphocyte subsets in type 2 diabetes. Brazilian Journal of Medical and Biological Research. 2016; 49.
    DOI  |   Google Scholar
  31. Qiao Y-C, Shen J, He L, Hong X-z, Tian F, Pan Y-H, et al. Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Journal of Diabetes Research. 2016; 2016.
    DOI  |   Google Scholar
  32. Amberbir A, Singano V, Matengeni A, Ismail Z, Kawalazira G, Chan AK, et al. Dyslipidemia among rural and urban HIV patients in south-east Malawi. PLoS One. 2018; 13(5): e0197728.
    DOI  |   Google Scholar
  33. Kagaruki GB, Mayige MT, Ngadaya ES, Kilale AM, Kahwa A, Shao AF, et al. Knowledge and perception on type2 diabetes and hypertension among HIV clients utilizing care and treatment services: a cross sectional study from Mbeya and Dar es Salaam regions in Tanzania. BMC Public Health. 2018; 18(1): 1-9.
    DOI  |   Google Scholar
  34. da Cunha GH, Franco KB, Galvão MTG, Lima MAC, Fontenele MSM, Siqueira LR, et al. Diabetes mellitus in people living with HIV/AIDS: prevalence and associated risk factors. AIDS Care. 2020; 32(5): 600-7.
    DOI  |   Google Scholar
  35. Hamilton MT, Hamilton DG, Zderic TW. Sedentary behavior as a mediator of type 2 diabetes. Diabetes and Physical Activity. 2014; 60: 11-26.
    DOI  |   Google Scholar
  36. Molina PE, Simon L, Amedee AM, Welsh DA, Ferguson TF. Impact of alcohol on HIV disease pathogenesis, comorbidities and aging: integrating preclinical and clinical findings. Alcohol and Alcoholism. 2018; 53(4): 439-47.
    DOI  |   Google Scholar
  37. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non—insulin-dependent diabetes mellitus in women. Jama. 1997; 277(6): 472-7.
    DOI  |   Google Scholar
  38. Samad F, Harris M, Puskas CM, Ye M, Chia J, Chacko S, et al. Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50. BMJ Open Diabetes Research and Care. 2017; 5(1): e000457.
    DOI  |   Google Scholar